When Randomized Clinical Trials and Real ‐World Evidence Say the Same: Tocilizumab and Its Cardiovascular Safety
Arthritis&Rheumatology, Volume 72, Issue 1, Page 4-6, January 2020.
Source: Arthritis and Rheumatology - Category: Rheumatology Authors: Seoyoung C. Kim,
Sebastian Schneeweiss Tags: Editorial Source Type: research
More News: Actemra | Arthritis | Cardiology | Cardiovascular | Clinical Trials | Heart | Rheumatology